首页> 外文期刊>Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique >Concomitant chemoradiotherapy of infiltrating cancers of the bladder
【24h】

Concomitant chemoradiotherapy of infiltrating cancers of the bladder

机译:浸润性膀胱癌的同时放化疗

获取原文
获取原文并翻译 | 示例
       

摘要

Until now, radical cystectomy has been considered the most effective treatment for invasive bladder cancer. However it fails to cure more than 50% of patients and can result in a mediocre quality of life. In an effort to improve cure rates, combined modality regimens have been investigated. Despite the preliminary results of early clinical trials, randomized trials have most often failed to show any benefit from neoadjuvant or adjuvant chemotherapy or radiotherapy. One of the major progress brought by radiotherapy has been the wide use of conservative treatment in several cancer, and in the recent years promising results have been published with concomitant radio-chemotherapy. The use of conservative approach in bladder cancer now appears to be a tangible reality for selected patients, but this combined modality have not yet been tested in randomized trials.
机译:迄今为止,根治性膀胱切除术一直被认为是浸润性膀胱癌最有效的治疗方法。但是,它无法治愈超过50%的患者,并可能导致中等质量的生活。为了提高治愈率,已经研究了联合治疗方案。尽管有早期临床试验的初步结果,但随机试验通常未能显示出新辅助或辅助化疗或放疗的任何益处。放射疗法带来的主要进展之一是在几种癌症中广泛使用了保守治疗,并且近年来,伴随放射化学疗法发表了令人鼓舞的结果。对于某些患者,在膀胱癌中使用保守治疗方法似乎已成为切实可行的现实,但是这种联合方式尚未在随机试验中进行测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号